Manipulation of host signalling pathways by anthrax toxins

Biochemical Journal

Volumn 402, Issue 3, 2007, Pages 405-417

  Turk, Benjamin E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenylate cyclase; Anthrax; Lethal factor; Metalloproteinase; Mitogen activated protein kinase pathway; Oedema factor

Indexed keywords

ANTIGENS; BACTERIA; CELL DEATH; ENZYMES; PATHOGENS; PROTEINS;

ADENYLATE CYCLASE; ANTHRAX; LETHAL FACTORS; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE PATHWAY; OEDEMA FACTORS;

TOXIC MATERIALS;

ADENYLATE CYCLASE; ANTHRAX TOXIN; CYCLIC AMP; GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; MAMMALIAN TARGET OF RAPAMYCIN; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; RANTES; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; BACILLUS ANTHRACIS; CELL DEATH; CYTOKINE PRODUCTION; DNA MICROARRAY; ENZYME MECHANISM; HOST CELL; HUMAN; IMMUNE SYSTEM; INNATE IMMUNITY; LETHAL GENE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW;

ADENYLATE CYCLASE; ANIMALS; ANTHRAX; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; HUMANS; MACROPHAGES; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; SIGNAL TRANSDUCTION;

BACILLUS ANTHRACIS; BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 33947256514     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20061891     Document Type: Review

References (171)

1. Turnbull, P. C. (2002) Introduction: anthrax history, disease and ecology. Curr. Top. Microbiol. Immunol. 271, 1-19
2. Dixon, T. C., Meselson, M., Guillemin, J. and Hanna, P. C. (1999) Anthrax. N. EngU.Med. 341, 815-826
3. Mock, M. and Fouet, A. (2001) Anthrax. Annu. Rev. Microbiol. 55, 647-671
4. Guidi-Rontani, C. and Mock, M. (2002) Macrophage interactions. Curr. Top. Microbiol. Immunol. 271, 115-141
5. Ribot, W. J., Panchal, R. G., Brittingham, K. C., Ruthel, G., Kenny, T. A., Lane, D., Curry, B., Hoover, T. A., Friedlander, A. M. and Bavari, S. (2006) Anthrax lethal toxin impairs innate immune functions of alveolar macrophages and facilitates Bacillus anthracis survival. Infect. Immun. 74, 5029-5034
6. Ruthel, G., Ribot, W. J., Bavari, S. and Hoover, T. A. (2004) Time-lapse confocal imaging of development of Bacillus anthracis in macrophages. J. Infect. Dis. 189, 1313-1316
7. Brittingham, K. C., Ruthel, G., Panchal, R. G., Fuller, C. L., Ribot, W. J., Hoover, T. A., Young, H. A., Anderson, A. O. and Bavari, S. (2005) Dendritic cells endocytose Bacillus anthracis spores: implications for anthrax pathogenesis. J. Immunol. 174, 5545-5552
8. Holty, J. E., Bravata, D. M., Liu, H., Olshen, R. A., McDonald, K. M. and Owens, D. K. (2006) Systematic review: a century of inhalational anthrax cases from 1900 to 2005. Ann. Intern. Med. 144, 270-280
9. Collier, R. J. and Young, J. A. (2003) Anthrax toxin. Annu. Rev. Cell Dev. Biol. 19, 45-70
10. Drysdale, M., Heninger, S., Hutt, J., Chen, Y., Lyons, C. R. and Koehler, T. M. (2005) Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax. EMBO J. 24, 221-227
11. Moayeri, M., Haines, D., Young, H. A. and Leppla, S. H. (2003) Bacillus anthracis lethal toxin induces TNF-α-independent hypoxia-mediated toxicity in mice. J. Clin. Invest. 112, 670-682
12. Gozes, Y., Moayeri, M., Wiggins, J. F. and Leppla, S. H. (2006) Anthrax lethal toxin induces ketotifen-sensitive intradermal vascular leakage in certain inbred mice. Infect. Immun. 74, 1266-1272
13. Firoved, A. M., Miller, G. F., Moayeri, M., Kakkar, R., Shen, Y., Wiggins, J. F., McNally, E. M., Tang, W. J. and Leppla, S. H. (2005) Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am. J. Pathol. 167, 1309-1320
14. Abramova, F. A., Grinberg, L. M., Yampolskaya, O. V. and Walker, D. H. (1993) Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc. Natl. Acad. Sci. U.S.A. 90, 2291-2294
15. Grinberg, L. M., Abramova, F. A., Yampolskaya, O. V., Walker, D. H. and Smith, J. H. (2001) Quantitative pathology of inhalational anthrax I: quantitative microscopic findings. Mod. Pathol. 14, 482-495
16. Burnett, J. C., Henchal, E. A., Schmaljohn, A. L. and Bavari, S. (2005) The evolving field of biodefence: therapeutic developments and diagnostics. Nat. Rev. Drug Discovery 4, 281-297
17. Shoop, W. L., Xiong, Y., Wiltsie, J., Woods, A., Guo, J., Pivnichny, J. V., Felcetto, T., Michael, B. F., Bansal, A., Cummings, R. T. et al. (2005) Anthrax lethal factor inhibition. Proc. Natl. Acad. Sci. U.S.A. 102, 7958-7963
18. Vitale, L., Blanset, D., Lowy, I., O'Neill, T., Goldstein, J., Little, S. F., Andrews, G. P., Dorough, G., Taylor, R. K. and Keler, T. (2006) Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity. Infect. Immun. 74, 5840-5847
19. Abrami, L., Reig, N. and van der Goot, F. G. (2005) Anthrax toxin: the long and winding road that leads to the kill. Trends Microbiol. 13, 72-78
20. Scobie, H. M. and Young, J. A. (2005) Interactions between anthrax toxin receptors and protective antigen. Curr. Opin. Microbiol. 8, 106-112
21. Moayeri, M. and Leppla, S. H. (2004) The roles of anthrax toxin in pathogenesis. Curr. Opin. Microbiol. 7, 19-24
22. Banks, D. J., Ward, S. C. and Bradley, K. A. (2006) New insights into the functions of anthrax toxin. Expert Rev. Mol. Med. 8, 1-18
23. Baldari, C. T., Tonello, F., Paccani, S. R. and Montecucco, C. (2006) Anthrax toxins: a paradigm of bacterial immune suppression. Trends Immunol. 27, 434-440
24. Fouet, A. and Mock, M. (2006) Regulatory networks for virulence and persistence of Bacillus anthracis. Curr. Opin. Microbiol. 9, 160-166
25. Rainey, G. J. and Young, J. A. (2004) Antitoxins: novel strategies to target agents of bioterrorism. Nat. Rev. Microbiol. 2, 721-726
26. Pannifer, A. D., Wong, T. Y., Schwarzenbacher, R., Renatus, M., Petosa, C., Bienkowska, J., Lacy, D. B., Collier, R. J., Park, S., Leppla, S. H. et al. (2001) Crystal structure of the anthrax lethal factor. Nature 414, 229-233
27. Arora, N. and Leppla, S. H. (1993) Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides. J. Biol. Chem. 268, 3334-3341
28. Milne, J. C., Blanke, S. R., Hanna, P. C. and Collier, R. J. (1995) Protective antigen-binding domain of anthrax lethal factor mediates translocation of a heterologous protein fused to its amino- or carboxy-terminus. Mol. Microbiol. 15, 661-666
29. Liang, X., Young, J. J., Boone, S. A., Waugh, D. S. and Duesbery, N. S. (2004) Involvement of domain II in toxicity of anthrax lethal factor. J. Biol. Chem. 279, 52473-52478
30. Duesbery, N. S., Webb, C. P., Leppla, S. H., Gordon, V. M., Klimpel, K. R., Copeland, T. D., Ahn, N. G., Oskarsson, M. K., Fukasawa, K., Paull, K. D. and Vande Woude, G. F. (1998) Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280, 734-737
31. Vitale, G., Bernardi, L., Napolitani, G., Mock, M. and Montecucco, C. (2000) Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem. J. 352, 739-745
32. Pellizzari, R., Guidi-Rontani, C., Vitale, G., Mock, M. and Montecucco, C. (1999) Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNγ-induced release of NO and TNFa. FEBS Lett. 462, 199-204
33. Vitale, G., Pellizzari, R., Recchi, C., Napolitani, G., Mock, M. and Montecucco, C. (1998) Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem. Biophys. Res. Commun. 248, 706-711
34. Chopra, A. P., Boone, S. A., Liang, X. and Duesbery, N. S. (2003) Anthrax lethal factor proteolysis and inactivation of MAPK kinase. J. Biol. Chem. 278, 9402-9406
35. Widmann, C., Gibson, S., Jarpe, M. B. and Johnson, G. L. (1999) Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79, 143-180
36. Chang, L. and Karin, M. (2001) Mammalian MAP kinase signalling cascades. Nature 410, 37-40
37. Guichard, A., Park, J. M., Cruz-Moreno, B., Karin, M. and Bier, E. (2006) Anthrax lethal factor and edema factor act on conserved targets in Drosophila. Proc. Natl. Acad. Sci. U.S.A. 103, 3244-3249
38. Sharrocks, A. D., Yang, S. H. and Galanis, A. (2000) Docking domains and substrate-specificity determination for MAP kinases. Trends Biochem. Sci. 25, 448-453
39. Tanoue, T. and Nishida, E. (2003) Molecular recognitions in the MAP kinase cascades. Cell. Signalling 15, 455-462
40. Bardwell, A. J., Abdollahi, M. and Bardwell, L. (2004) Anthrax lethal factor-cleavage products of MARK (mitogen-activated protein kinase) kinases exhibit reduced binding to their cognate MAPKs. Biochem. J. 378, 569-577
41. Bardwell, L. and Thorner, J. (1996) A conserved motif at the amino termini of MEKs might mediate high-affinity interaction with the cognate MAPKs. Trends Biochem. Sci. 21, 373-374
42. Ho, D. T., Bardwell, A. J., Abdollahi, M. and Bardwell, L. (2003) A docking site in MKK4 mediates high affinity binding to JNK MAPKs and competes with similar docking sites in JNK substrates. J. Biol. Chem. 278, 32662-32672
43. Ho, D. T., Bardwell, A. J., Grewal, S., Iverson, C. and Bardwell, L. (2006) Interacting JNK-docking sites in MKK7 promote binding and activation of JNK MAP kinases. J. Biol. Chem. 281, 13169-13179
44. Liu, S., Sun, J. P., Zhou, B. and Zhang, Z. Y. (2006) Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3. Proc. Natl. Acad. Sci. U.S.A. 103, 5326-5331
45. Zhou, T., Sun, L., Humphreys, J. and Goldsmith, E. J. (2006) Docking interactions induce exposure of activation loop in the MAP kinase ERK2. Structure 14, 1011-1019
46. Lee, T., Hoofnagle, A. N., Kabuyama, Y., Stroud, J., Min, X., Goldsmith, E. J., Chen, L., Resing, K. A. and Ahn, N. G. (2004) Docking motif interactions in MAP kinases revealed by hydrogen exchange mass spectrometry. Mol. Cell 14, 43-55
47. Zhang, F., Strand, A., Robbins, D., Cobb, M. H. and Goldsmith, E. J. (1994) Atomic structure of the MAP kinase ERK2 at 2.3 Å resolution. Nature 367, 704-711
48. Chang, C. I., Xu, B. E., Akella, R., Cobb, M. H. and Goldsmith, E. J. (2002) Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. Mol. Cell 9, 1241-1249
49. Heo, Y. S., Kim, S. K., Seo, C. I., Kim, Y. K., Sung, B. J., Lee, H. S., Lee, J. I., Park, S. Y., Kim, J. H., Hwang, K. Y. et al. (2004) Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125. EMBO J. 23, 2185-2195
50. Canagarajah, B. J., Khokhlatchev, A., Cobb, M. H. and Goldsmith, E. J. (1997) Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell 90, 859-869
51. Park, J. M., Greten, F. R., Li, Z. W. and Karin, M. (2002) Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297, 2048-2051
52. Turk, B. E., Wong, T. Y., Schwarzenbacher, R., Jarrell, E. T., Leppla, S. H., Collier, R. J., Liddington, R. C. and Cantley, L. C. (2004) The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor. Nat. Struct. Mol. Biol. 11, 60-66
53. Ohren, J. F., Chen, H., Pavlovsky, A., Whitehead, C., Zhang, E., Kuffa, P., Yan, C., McConnell, P., Spessard, C., Banotai, C. et al. (2004) Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition. Nat. Struct. Mol. Biol. 11, 1192-1197
54. Wright, G. G. and Mandell, G. L. (1986) Anthrax toxin blocks priming of neutrophils by lipopolysaccharide and by muramyl dipeptide. J. Exp. Med. 164, 1700-1709
55. During, R. L., Li, W., Hao, B., Koenig, J. M., Stephens, D. S., Quinn, C. P and Southwick, F. S. (2005) Anthrax lethal toxin paralyzes neutrophil actin-based motility. J. Infect. Dis. 192, 837-845
56. Crawford, M. A., Aylott, C. V., Bourdeau, R. W. and Bokoch, G. M. (2006) Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity. J. Immunol. 176, 7557-7565
57. Zu, Y. L., Qi, J., Gilchrist, A., Fernandez, G. A., Vazquez-Abad, D., Kreutzer, D. L., Huang, C. K. and Sha'afi, R. I. (1998) p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-α or FMLP stimulation. J. Immunol. 160, 1982-1989
58. Hii, C. S., Stacey, K., Moghaddami, N., Murray, A. W. and Ferrante, A. (1999) Role of the extracellular signal-regulated protein kinase cascade in human neutrophil killing of Staphylococcus aureus and Candida albicans and in migration. Infect. Immun. 67, 1297-1302
59. Cara, D. C., Kaur, J., Forster, M., McCafferty, D. M. and Kubes, P. (2001) Role of p38 mitogen-activated protein kinase in chemokine-induced emigration and chemotaxis in vivo. J. Immunol. 167, 6552-6558
60. Coxon, P. Y., Rane, M. J., Uriarte, S., Powell, D. W., Singh, S., Butt, W., Chen, Q. and McLeish, K. R. (2003) MAPK-activated protein kinase-2 participates in p38 MAPK-dependent and ERK-dependent functions in human neutrophils. Cell. Signalling 15, 993-1001
61. Downey, G. P., Butler, J. R., Tapper, H., Fialkow, L., Saltiel, A. R., Rubin, B. B. and Grinstein, S. (1998) Importance of MEK in neutrophil microbicidal responsiveness. J. Immunol. 160, 434-443
62. phox phosphorylation in human neutrophils. J. Immunol. 165, 5238-5244
63. Brown, G. E., Stewart, M. Q., Bissonnette, S. A., Elia, A. E., Wilker, E. and Yaffe, M. B. (2004) Distinct ligand-dependent roles for p38 MAPK in priming and activation of the neutrophil NADPH oxidase. J. Biol. Chem. 279, 27059-27068
64. phox-serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites. J. Clin. Invest. 116, 2033-2043
65. Nick, J. A., Young, S. K., Arndt, P. G., Lieber, J. G., Suratt, B. T., Poch, K. R., Avdi, N. J., Malcolm, K. C., Taube, C., Henson, P. M. and Worthen, G. S. (2002) Selective suppression of neutrophil accumulation in ongoing pulmonary inflammation by systemic inhibition of p38 mitogen-activated protein kinase. J. Immunol. 169, 5260-5269
66. Janeway, Jr, C. A. and Medzhitov, R. (2002) Innate immune recognition. Annu. Rev. Immunol. 20, 197-216
67. Guha, M. and Mackman, N. (2001) LPS induction of gene expression in human monocytes. Cell. Signalling 13, 85-94
68. Dumitru, C. D., Ceci, J. D., Tsatsanis, C., Kontoyiannis, D., Stamatakis, K., Lin, J. H., Patriotis, C., Jenkins, N. A., Copeland, N. G., Kollias, G. and Tsichlis, P. N. (2000) TNF-α induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. Cell 103, 1071-1083
69. Xu, Z., Dziarski, R., Wang, Q., Swartz, K., Sakamoto, K. M. and Gupta, D. (2001) Bacterial peptidoglycan-induced TNF-α transcription is mediated through the transcription factors Egr-1 Elk-1, and NF-κB. J. Immunol. 167, 6975-6982
70. Guha, M., O'Connell, M. A., Pawlinski, R., Hollis, A., McGovern, P., Yan, S. F., Stern, D. and Mackman, N. (2001) Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor α expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98, 1429-1439
71. Kotlyarov, A., Neininger, A., Schubert, C., Eckert, R., Birchmeier, C., Volk, H. D. and Gaestel, M. (1999) MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis. Nat. Cell Biol. 1, 94-97
72. Neininger, A., Kontoyiannis, D., Kotlyarov, A., Winzen, R., Eckert, R., Volk, H. D., Holtmann, H., Kollias, G. and Gaestel, M. (2002) MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels. J. Biol. Chem. 277, 3065-3068
73. Rousseau, S., Morrice, N., Peggie, M., Campbell, D. G., Gaestel, M. and Cohen, P. (2002) Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs. EMBO J. 21, 6505-6514
74. Popov, S. G., Villasmil, R., Bernardi, J., Grene, E., Cardwell, J., Popova, T., Wu, A., Alibek, D., Bailey, C. and Alibek, K. (2002) Effect of Bacillus anthracis lethal toxin on human peripheral blood mononuclear cells. FEBS Lett. 527, 211-215
75. + lung cells are impaired by anthrax toxins after spore infection. J. Infect. Dis. 194, 86-94
76. Comer, J. E., Galindo, C. L., Chopra, A. K. and Peterson, J. W. (2005) GeneChip analyses of global transcriptional responses of murine macrophages to the lethal toxin of Bacillus anthracis. Infect. Immun. 73, 1879-1885
77. Shi, L., Kishore, R., McMullen, M. R. and Nagy, L. E. (2002) Lipopolysaccharide stimulation of ERK1/2 increases TNF-α production via Egr-1. Am. J. Physiol. Cell Physiol. 282, C1205-C1211
78. Dang, O., Navarro, L., Anderson, K. and David, M. (2004) Cutting edge: anthrax lethal toxin inhibits activation of IFN-regulatory factor 3 by lipopolysaccharide. J. Immunol. 172, 747-751
79. Agrawal, A., Lingappa, J., Leppla, S. H., Agrawal, S., Jabbar, A., Quinn, C. and Pulendran, B. (2003) Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin. Nature 424, 329-334
80. Tournier, J. N., Quesnel-Hellmann, A., Mathieu, J., Montecucco, C., Tang, W. J., Mock, M., Vidal, D. R. and Goossens, P. L. (2005) Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells. J. Immunol. 174, 4934-4941
81. Comer, J. E., Chopra, A. K., Peterson, J. W. and Konig, R. (2005) Direct inhibition of T-lymphocyte activation by anthrax toxins in vivo. Infect. Immun. 73, 8275-8281
82. + T cells. J. Immunol. 174, 4966-4971
83. Fang, H., Xu, L., Chen, T. Y., Cyr, J. M. and Frucht, D. M. (2006) Anthrax lethal toxin has direct and potent inhibitory effects on B cell proliferation and immunoglobulin production. J. Immunol. 176, 6155-6161
84. Moayeri, M., Webster, J. I., Wiggins, J. F., Leppla, S. H. and Sternberg, E. M. (2005) Endocrine perturbation increases susceptibility of mice to anthrax lethal toxin. Infect. Immun. 73, 4238-4244
85. Webster, J. I. and Sternberg, E. M. (2005) Anthrax lethal toxin represses glucocorticoid receptor (GR) transactivation by inhibiting GR-DNA binding in vivo. Mol. Cell. Endocrinol. 241, 21-31
86. Webster, J. I., Tonelli, L. H., Moayeri, M., Simons, Jr, S. S., Leppla, S. H. and Sternberg, E. M. (2003) Anthrax lethal factor represses glucocorticoid and progesterone receptor activity. Proc. Natl. Acad. Sci. U.S.A. 100, 5706-5711
87. Kirby, J. E. (2004) Anthrax lethal toxin induces human endothelial cell apoptosis. Infect. Immun. 72, 430-439
88. Warfel, J. M., Steele, A. D. and D'Agnillo, F. (2005) Anthrax lethal toxin induces endothelial barrier dysfunction. Am. J. Pathol. 166, 1871-1881
89. Kim, S. O., Jing, Q., Hoebe, K., Beutler, B., Duesbery, N. S. and Han, J. (2003) Sensitizing anthrax lethal toxin-resistant macrophages to lethal toxin-induced killing by tumor necrosis factor-α. J. Biol. Chem. 278, 7413-7421
90. Kassam, A., Der, S. D. and Mogridge, J. (2005) Differentiation of human monocytic cell lines confers susceptibility to Bacillus anthracis lethal toxin. Cell. Microbiol. 7, 281-292
91. Alileche, A., Serfass, E. R., Muehlbauer, S. M., Porcelli, S. A. and Brojatsch, J. (2005) Anthrax lethal toxin-mediated killing of human and murine dendritic cells impairs the adaptive immune response. PLoS Pathog. 1, e19
92. Hanna, P. C., Kochi, S. and Collier, R. J. (1992) Biochemical and physiological changes induced by anthrax lethal toxin in J774 macrophage-like cells. Mol. Biol. Cell 3, 1269-1277
93. Alileche, A., Squires, R. C., Muehlbauer, S. M., Lisanti, M. P. and Brojatsch, J. (2006) Mitochondrial impairment is a critical event in anthrax lethal toxin-induced cytolysis of murine macrophages. Cell Cycle 5, 100-106
94. Hanna, P. C., Kruskal, B. A., Ezekowitz, R. A., Bloom, B. R. and Collier, R. J. (1994) Role of macrophage oxidative burst in the action of anthrax lethal toxin. Mol. Med. 1, 7-18
95. Tang, G. and Leppla, S. H. (1999) Proteasome activity is required for anthrax lethal toxin to kill macrophages. Infect. Immun. 67, 3055-3060
96. Bhatnagar, R. and Friedlander, A. M. (1994) Protein synthesis is required for expression of anthrax lethal toxin cytotoxicity. Infect. Immun. 62, 2958-2962
97. Bhatnagar, R., Singh, Y., Leppla, S. H. and Friedlander, A. M. (1989) Calcium is required for the expression of anthrax lethal toxin activity in the macrophage-like cell line J774A.1. Infect. Immun. 57, 2107-2114
98. Chandra, H., Gupta, P. K., Sharma, K., Mattoo, A. R., Garg, S. K., Gade, W. N., Sirdeshmukh, R., Maithal, K. and Singh, Y. (2005) Proteome analysis of mouse macrophages treated with anthrax lethal toxin. Biochim. Biophys. Acta 1747, 151-159
99. Kuhn, J. F., Hoerth, P., Hoehn, S. T., Preckel, T. and Tomer, K. B. (2006) Proteomics study of anthrax lethal toxin-treated murine macrophages. Electrophoresis 27, 1584-1597
100. Sapra, R., Gaucher, S. P., Lachmann, J. S., Buffleben, G. M., Chirica, G. S., Comer, J. E., Peterson, J. W., Chopra, A. K. and Singh, A. K. (2006) Proteomic analyses of murine macrophages treated with Bacillus anthracis lethal toxin. Microb. Pathog. 41, 157-167
101. Boyden, E. D. and Dietrich, W. F. (2006) Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat. Genet. 38, 240-244
102. Watters, J. W. and Dietrich, W. F. (2001) Genetic, physical, and transcript map of the Ltxs1 region of mouse chromosome 11. Genomics 73, 223-231
103. Tschopp, J., Martinon, F. and Burns, K. (2003) NALPs: a novel protein family involved in inflammation. Nat. Rev. Mol. Cell Biol. 4, 95-104
104. Inohara, N., Chamaillard, M., McDonald, C. and Nunez, G. (2005) NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annu. Rev. Biochem. 74, 355-383
105. Kanneganti, T. D., Ozoren, N., Body-Malapel, M., Amer, A., Park, J. H., Franchi, L., Whitfield, J., Barchet, W., Colonna, M., Vandenabeele, P. et al. (2006) Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440, 233-236
106. Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N. and Tschopp, J. (2004) NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20, 319-325
107. Martinon, F., Burns, K. and Tschopp, J. (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 10, 417-426
108. Sutterwala, F. S., Ogura, Y., Szczepanik, M., Lara-Tejero, M., Lichtenberger, G. S., Grant, E. P., Bertin, J., Coyle, A. J., Galan, J. E., Askenase, P. W. and Flavell, R. A. (2006) Critical role for NALP3/CIAS1/ cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24, 317-327
109. Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M. and Dixit, V. M. (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228-232
110. Cordoba-Rodriguez, R., Fang, H., Lankford, C. S. and Frucht, D. M. (2004) Anthrax lethal toxin rapidly activates caspase-1/ICE and induces extracellular release of interleukin (IL)-1β and IL-18. J. Biol. Chem. 279, 20563-20566
111. Martinon, F., Agostini, L., Meylan, E. and Tschopp, J. (2004) Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr. Biol. 14, 1929-1934
112. Hilbi, H., Moss, J. E., Hersh, D., Chen, Y., Arondel, J., Banerjee, S., Flavell, R. A., Yuan, J., Sansonetti, P. J. and Zychlinsky, A. (1998) Shigella-induced apoptosis is dependent on caspase-1 which binds to IpaB. J. Biol. Chem. 273, 32895-32900
113. Hersh, D., Monack, D. M., Smith, M. R., Ghori, N., Falkow, S. and Zychlinsky, A. (1999) The Salmonella invasin SipB induces macrophage apoptosis by binding to caspase-1. Proc. Natl. Acad. Sci. U.S.A. 96, 2396-2401
114. Brennan, M. A. and Cookson, B. T. (2000) Salmonella induces macrophage death by caspase-1-dependent necrosis. Mol. Microbiol. 38, 31-40
115. Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S. and Dixit, V. M. (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213-218
116. Welkos, S. L., Keener, T. J. and Gibbs, P. H. (1986) Differences in susceptibility of inbred mice to Bacillus anthracis. Infect. Immun. 51, 795-800
117. Sansonetti, P. J., Phalipon, A., Arondel, J., Thirumalai, K., Banerjee, S., Akira, S., Takeda, K. and Zychlinsky, A. (2000) Caspase-1 activation of IL-1β and IL-18 are essential for Shigella flexneri-induced inflammation. Immunity 12, 581-590
118. Monack, D. M., Hersh, D., Ghori, N., Bouley, D., Zychlinsky, A. and Falkow, S. (2000) Salmonella exploits caspase-1 to colonize Peyer's patches in a murine typhoid model. J. Exp. Med. 192, 249-258
119. Lara-Tejero, M., Sutterwala, F. S., Ogura, Y., Grant, E. P., Bertin, J., Coyle, A. J., Flavell, R. A. and Galan, J. E. (2006) Role of the caspase-1 inflammasome in Salmonella typhimurium pathogenesis. J. Exp. Med. 203, 1407-1412
120. McAllister, R. D., Singh, Y., du Bois, W. D., Potter, M., Boehm, T., Meeker, N. D., Fillmore, P. D., Anderson, L. M., Poynter, M. E. and Teuscher, C. (2003) Susceptibility to anthrax lethal toxin is controlled by three linked quantitative trait loci. Am. J. Pathol. 163, 1735-1741
121. Moayeri, M., Martinez, N. W., Wiggins, J., Young, H. A. and Leppla, S. H. (2004) Mouse susceptibility to anthrax lethal toxin is influenced by genetic factors in addition to those controlling macrophage sensitivity. Infect. Immun. 72, 4439-4447
122. Tucker, A. E., Salles, I. I., Voth, D. E., Ortiz-Leduc, W., Wang, H., Dozmorov, I., Centola, M. and Ballard, J. D. (2003) Decreased glycogen synthase kinase 3-β levels and related physiological changes in Bacillus anthracis lethal toxin-treated macrophages. Cell. Microbiol. 5, 523-532
123. Cohen, P. and Frame, S. (2001) The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2, 769-776
124. Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M. S., Jin, O. and Woodgett, J. R. (2000) Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation. Nature 406, 86-90
125. Monick, M. M., Carter, A. B., Robeff, P. K., Flaherty, D. M., Peterson, M. W. and Hunninghake, G. W. (2001) Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of β-catenin. J. Immunol. 166, 4713-4720
126. Wei, W., Lu, Q., Chaudry, G. J., Leppla, S. H. and Cohen, S. N. (2006) The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin. Cell 124, 1141-1154
127. Park, J. M., Ng, V. H., Maeda, S., Rest, R. F. and Karin, M. (2004) Anthrolysin O and other Gram-positive cytolysins are toll-like receptor 4 agonists. J. Exp. Med. 200, 1647-1655
128. Popov, S. G., Villasmil, R., Bernardi, J., Grene, E., Cardwell, J., Wu, A., Alibek, D., Bailey, C. and Alibek, K. (2002) Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. Biochem. Biophys. Res. Commun. 293, 349-355
129. Kau, J. H., Lin, C. G., Huang, H. H., Hsu, H. L., Chen, K. C., Wu, Y. P. and Lin, H. C. (2002) Calyculin A sensitive protein phosphatase is required for Bacillus anthracis lethal toxin induced cytotoxicity. Curr. Microbiol. 44, 106-111
130. Park, J. M., Greten, F. R., Wong, A., Westrick, R. J., Arthur, J. S., Otsu, K., Hoffmann, A., Montminy, M. and Karin, M. (2005) Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis-CREB and NF-κB as key regulators. Immunity 23, 319-329
131. Mayr, B. and Montminy, M. (2001) Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2, 599-609
132. Deak, M., Clifton, A. D., Lucocq, L. M. and Alessi, D. R. (1998) Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 17, 4426-4441
133. Danial, N. N. and Korsmeyer, S. J. (2004) Cell death: critical control points. Cell 116, 205-219
134. Dickinson, J. L., Bates, E. J., Ferrante, A. and Antalis, T. M. (1995) Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor α-induced apoptosis: evidence for an alternate biological function. J. Biol. Chem. 270, 27894-27904
135. Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A. and Greenberg, M. E. (1999) Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286, 1358-1362
136. Shimamura, A., Ballif, B. A., Richards, S. A. and Blenis, J. (2000) Rsk1 mediates a MEK-MAP kinase cell survival signal. Curr. Biol. 10, 127-135
137. Hacker, G., Suttner, K., Harada, H. and Kirschnek, S. (2006) TLR-dependent Bim phosphorylation in macrophages is mediated by ERK and is connected to proteasomal degradation of the protein. Int. Immunol. 18, 1749-1757
138. Callsen, D. and Brune, B. (1999) Role of mitogen-activated protein kinases in S-nitrosoglutathione-induced macrophage apoptosis. Biochemistry 38, 2279-2286
139. Devries-Seimon, T., Li, Y., Yao, P. M., Stone, E., Wang, Y., Davis, R. J., Flavell, R. and Tabas, I. (2005) Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor. J. Cell Biol. 171, 61-73
140. Kirschnek, S., Ying, S., Fischer, S. F., Hacker, H., Villunger, A., Hochrein, H. and Hacker, G. (2005) Phagocytosis-induced apoptosis in macrophages is mediated by up-regulation and activation of the Bcl-2 homology domain 3-only protein Bim. J. Immunol. 174, 671-679
141. Himes, S. R., Sester, D. P., Ravasi, T., Cronau, S. L., Sasmono, T. and Hume, D. A. (2006) The JNK are important for development and survival of macrophages. J. Immunol. 176, 2219-2228
142. Lei, K. and Davis, R. J. (2003) JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc. Natl. Acad. Sci. U.S.A. 100, 2432-2437
143. Lamb, J. A., Ventura, J. J., Hess, P., Flavell, R. A. and Davis, R. J. (2003) JunD mediates survival signaling by the JNK signal transduction pathway. Mol. Cell 11, 1479-1489
144. Hsu, L. C., Park, J. M., Zhang, K., Luo, J. L., Maeda, S., Kaufman, R. J., Eckmann, L., Guiney, D. G. and Karin, M. (2004) The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428, 341-345
145. Williams, B. R. (2001) Signal integration via PKR. Sci. STKE 2001, RE2
146. Mukherjee, S., Keitany, G., Li, Y., Wang, Y., Ball, H. L., Goldsmith, E. J. and Orth, K. (2006) Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312, 1211-1214
147. Orth, K. (2002) Function of the Yersinia effector YopJ. Curr. Opin. Microbiol. 5, 38-43
148. Zhang, Y., Ting, A. T., Marcu, K. B. and Bliska, J. B. (2005) Inhibition of MAPK and NF-κB pathways is necessary for rapid apoptosis in macrophages infected with Yersinia. J. Immunol. 174, 7939-7949
149. Ahuja, N., Kumar, P. and Bhatnagar, R. (2004) The adenylate cyclase toxins. Crit. Rev. Microbiol. 30, 187-196
150. Drum, C. L., Yan, S. Z., Bard, J., Shen, Y. Q., Lu, D., Soelaiman, S., Grabarek, Z., Bohm, A. and Tang, W. J. (2002) Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin. Nature 415, 396-402
151. Shen, Y., Zhukovskaya, N. L., Guo, Q., Florian, J. and Tang, W. J. (2005) Calcium-independent calmodulin binding and two-metal-ion catalytic mechanism of anthrax edema factor. EMBO J. 24, 929-941
152. Lacy, D. B., Mourez, M., Fouassier, A. and Collier, R. J. (2002) Mapping the anthrax protective antigen binding site on the lethal and edema factors. J. Biol. Chem. 277, 3006-3010
153. Guo, Q., Shen, Y., Lee, Y. S., Gibbs, C. S., Mrksich, M. and Tang, W. J. (2005) Structural basis for the interaction of Bordetella pertussis adenylyl cyclase toxin with calmodulin. EMBO J. 24, 3190-3201
154. O'Brien, J., Friedlander, A., Dreier, T., Ezzell, J. and Leppla, S. (1985) Effects of anthrax toxin components on human neutrophils. Infect. Immun. 47, 306-310
155. Friedman, R. L., Fiederlein, R. L., Glasser, L. and Galgiani, J. N. (1987) Bordetella pertussis adenylate cyclase: effects of affinity-purified adenylate cyclase on human polymorphonuclear leukocyte functions. Infect. Immun. 55, 135-140
156. phox phosphorylation and translocation. Biochem. Pharmacol. 67, 183-190
157. 2+ influx. J. Biol. Chem. 270, 23816-23822
158. Smith, F. D. and Scott, J. D. (2002) Signaling complexes: junctions on thé intracellular information super highway. Curr. Biol. 12, R32-R40
159. Howe, A. K. (2004) Regulation of actin-based cell migration by cAMP/PKA. Biochim. Biophys. Acta 1692, 159-174
160. DiPilato, L. M., Cheng, X. and Zhang, J. (2004) Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments. Proc. Natl. Acad. Sci. U.S.A. 101, 16513-16518
161. Jones, S. L. and Sharief, Y. (2005) Asymmetrical protein kinase A activity establishes neutrophil cytoskeletal polarity and enables chemotaxis. J. Leukocyte Biol. 78, 248-258
162. Dal Molin, F., Tonello, F., Ladant, D., Zornetta, I., Zamparo, I., Di Benedetto, G., Zaccolo, M. and Montecucco, C. (2006) Cell entry and cAMP imaging of anthrax edema toxin. EMBO J. 25, 5405-5413
163. Hoover, D. L., Friedlander, A. M., Rogers, L. C., Yoon, I. K., Warren, R. L. and Cross, A. S. (1994) Anthrax edema toxin differentially regulates lipopolysaccharide-induced monocyte production of tumor necrosis factor α and interleukin-6 by increasing intracellular cyclic AMP. Infect. Immun. 62, 4432-4439
164. Willis, S. A. and Nisen, P. D. (1996) Differential induction of the mitogen-activated protein kinase pathway by bacterial lipopolysaccharide in cultured monocytes and astrocytes. Biochem. J. 313, 519-524
165. Dziarski, R., Jin, Y. P. and Gupta, D. (1996) Differential activation of extracellular signal-regulated kinase (ERK) 1, ERK2, p38, and c-Jun NH2-terminal kinase mitogen-activated protein kinases by bacterial peptidoglycan. J. Infect. Dis. 174, 777-785
166. Delgado, M. and Ganea, D. (2000) Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in LPS-stimulated macrophages. J. Neuroimmunol. 110, 97-105
167. Aronoff, D. M., Canetti, C., Serezani, C. H., Luo, M. and Peters-Golden, M. (2005) Cutting edge: macrophage inhibition by cyclic AMP (cAMP): differential roles of protein kinase A and exchange protein directly activated by cAMP-1. J. Immunol. 174, 595-599
168. Bryn, T., Mahic, M., Enserink, J. M., Schwede, F., Aandahl, E. M. and Tasken, K. (2006) The cyclic AMP-Epad-Rap1 pathway is dissociated from regulation of effector functions in monocytes but acquires immunoregulatory function in mature macrophages. J. Immunol. 176, 7361-7370
169. Voth, D. E., Hamm, E. E., Nguyen, L G., Tucker, A. E., Salles, I. I., Ortiz-Leduc, W. and Ballard, J. D. (2005) Bacillus anthracis oedema toxin as a cause of tissue necrosis and cell type-specific cytotoxicity. Cell. Microbiol. 7, 1139-1149
170. Maldonado-Arocho, F J., Fulcher, J. A., Lee, B. and Bradley, K. A. (2006) Anthrax oedema toxin induces anthrax toxin receptor expression in monocyte-derived cells. Mol. Microbiol. 61, 324-337
171. Koo, H. M., VanBrocklin, M., McWilliams, M. J., Leppla, S. H., Duesbery, N. S. and Woude, G. F. (2002) Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase. Proc. Natl. Acad. Sci. U.S.A. 99, 3052-3057